Literature DB >> 2987913

Beta-endorphin-(1-27) is a naturally occurring antagonist to etorphine-induced analgesia.

P Nicolas, C H Li.   

Abstract

The potent opioid peptide beta-endorphin is found in the brain and pituitary with two related fragments, beta-endorphin-(1-27) and beta-endorphin-(1-26). The fragments retain substantial opioid-receptor binding activity but are virtually inactive analgesically. beta-Endorphin-(1-27) inhibits beta-endorphin-induced and etorphine-induced analgesia when coinjected intracerebroventricularly into mice. Antagonism by competition at the same site(s) is suggested from parallel shifts of the dose-response curves of etorphine or beta-endorphin in the presence of beta-endorphin-(1-27). Its potency is 4-5 times greater than that of the opiate antagonist naloxone. beta-Endorphin-(1-26) does not antagonize the antinociceptive action of etorphine or beta-endorphin in doses up to 500 pmol per animal.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987913      PMCID: PMC397738          DOI: 10.1073/pnas.82.10.3178

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Analgesic activity of lipotropin C fragment depends on carboxyl terminal tetrapeptide.

Authors:  M J Geisow; J F Deakin; J O Dostrovsky; D G Smyth
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

2.  beta-endorphin is a potent analgesic agent.

Authors:  H H Loh; L F Tseng; E Wei; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

3.  Endorphins are stored in biologically active and inactive forms: isolation of alpha-N-acetyl peptides.

Authors:  D G Smyth; D E Massey; S Zakarian; M D Finnie
Journal:  Nature       Date:  1979-05-17       Impact factor: 49.962

4.  Quantitative studies of the antagonism of morphine by nalorphine and naloxone.

Authors:  A E Takemori; H J Kupferberg; J W Miller
Journal:  J Pharmacol Exp Ther       Date:  1969-09       Impact factor: 4.030

5.  C-fragment of lipotropin--an endogenous potent analgesic peptide.

Authors:  W Feldberg; D G Smyth
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

6.  Synthesis and analgesic activity of human beta-endorphin.

Authors:  C H Li; D Yamashiro; L F Tseng; H H Loh
Journal:  J Med Chem       Date:  1977-03       Impact factor: 7.446

7.  Synthesis and opiate activity of human beta-endorphin analogs with various chain lengths.

Authors:  H W Yeung; D Yamashiro; W C Chang; C H Li
Journal:  Int J Pept Protein Res       Date:  1978-07

8.  Isolation of the C-fragment and C'-fragment of lipotropin from pig pituitary and C-fragment from brain.

Authors:  D G Smyth; C R Snell; D E Massey
Journal:  Biochem J       Date:  1978-10-01       Impact factor: 3.857

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  The synthesis and opiate activity of human beta-endorphin analogs. Substituted at residue positions 27 and 31.

Authors:  J Blake; L F Tseng; W C Chang; C H Li
Journal:  Int J Pept Protein Res       Date:  1978-05
View more
  12 in total

1.  β-Endorphin antagonizes the effects of α-MSH on food intake and body weight.

Authors:  Roxanne Dutia; Kana Meece; Shveta Dighe; Andrea J Kim; Sharon L Wardlaw
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

2.  Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens.

Authors:  Nesrin Filiz Basaran; R Levent Buyukuysal; William R Millington; Sinan Cavun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

Review 3.  Hypothalamic proopiomelanocortin processing and the regulation of energy balance.

Authors:  Sharon L Wardlaw
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

4.  Beta-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids.

Authors:  R Bals-Kubik; A Herz; T S Shippenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

Review 5.  Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions.

Authors:  Lloyd D Fricker; Elyssa B Margolis; Ivone Gomes; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2020-06-02       Impact factor: 4.436

6.  Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.

Authors:  M Hong; M Sutak; K Jhamandas
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

Review 7.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

8.  Reduced melanocortin production causes sexual dysfunction in male mice with POMC neuronal insulin and leptin insensitivity.

Authors:  Latrice D Faulkner; Abigail R Dowling; Ronald C Stuart; Eduardo A Nillni; Jennifer W Hill
Journal:  Endocrinology       Date:  2015-01-15       Impact factor: 4.736

9.  Biased signaling by endogenous opioid peptides.

Authors:  Ivone Gomes; Salvador Sierra; Lindsay Lueptow; Achla Gupta; Shawn Gouty; Elyssa B Margolis; Brian M Cox; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-11       Impact factor: 11.205

10.  The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake.

Authors:  Leona Plum; Hua V Lin; Roxanne Dutia; Jun Tanaka; Kumiko S Aizawa; Michihiro Matsumoto; Andrea J Kim; Niamh X Cawley; Ji-Hye Paik; Y Peng Loh; Ronald A DePinho; Sharon L Wardlaw; Domenico Accili
Journal:  Nat Med       Date:  2009-09-20       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.